The first patient has been enrolled at Lille's Hospital on February 9th 2016
The FAIR PARK II 4th annual meeting was held in Lisbon, Portugal on June 15th and 16th 2018
The FAIR PARK II 3rd annual meeting was held in Amsterdam, Netherlands on June 26th and 27th 2017
The FAIR PARK II 2nd annual meeting was held in Berlin, Germany on June 23rd and 24th 2016
The FAIR-PARK II kick-off meeting was held in Lille, France on 4-5 May 2015
The final list of European expert centres for the clinical trial will be available in October 2015
The final version of the study protocol, as submitting to regulators and ethics committees, will be available in January 2016.
Patient Recruitment Countdown
6th November 2019
Patients to be recruited
13
Patients recruited
359
Find out more about Fair Park II from Prof David Devos, the project coordinator
FAIR PARK II
Conservative iron chelation as a disease modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomised clinical trial of deferiprone
People
Scientific Coordinator: Prof David Devos
Project Manager (CHRUL): Pauline Guyon pauline.guyon@chru-lille.fr
Senior Project Manager (IT): Delphine Smagghe delphine.smagghe@inserm-transfert.fr
Project Manager (IT): Stephanie Le Naour stephanie.lenaour@inserm-transfert.fr
Addresses
Centre Hospitalier Regional et Universitaire de Lille (CHRUL), 2 avenue Oscar Lambret - 59037 Lille Cedex
Inserm-Transfert (IT), 7 rue de Watt - 75013 Paris, France